InflaRx Current Deferred Revenue from 2010 to 2024

IFRX Stock  USD 2.36  0.05  2.16%   
InflaRx NV Current Deferred Revenue yearly trend continues to be fairly stable with very little volatility. Current Deferred Revenue will likely drop to 0.95 in 2024. Current Deferred Revenue is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. View All Fundamentals
 
Current Deferred Revenue  
First Reported
2010-12-31
Previous Quarter
1
Current Value
0.95
Quarterly Volatility
1.6 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check InflaRx NV financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among InflaRx NV's main balance sheet or income statement drivers, such as Interest Income of 3.2 M, Discontinued Operations of 0.0 or Depreciation And Amortization of 342.2 K, as well as many indicators such as Price To Sales Ratio of 788, Dividend Yield of 0.0 or PTB Ratio of 0.83. InflaRx financial statements analysis is a perfect complement when working with InflaRx NV Valuation or Volatility modules.
  
Check out the analysis of InflaRx NV Correlation against competitors.
For more information on how to buy InflaRx Stock please use our How to Invest in InflaRx NV guide.

Latest InflaRx NV's Current Deferred Revenue Growth Pattern

Below is the plot of the Current Deferred Revenue of InflaRx NV over the last few years. It is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. InflaRx NV's Current Deferred Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in InflaRx NV's overall financial position and show how it may be relating to other accounts over time.
Current Deferred Revenue10 Years Trend
Slightly volatile
   Current Deferred Revenue   
       Timeline  

InflaRx Current Deferred Revenue Regression Statistics

Arithmetic Mean790,573
Geometric Mean20,708
Coefficient Of Variation205.15
Mean Deviation1,038,097
Median15,000
Standard Deviation1,621,839
Sample Variance2.6T
Range6.2M
R-Value0.44
Mean Square Error2.3T
R-Squared0.19
Significance0.10
Slope158,719
Total Sum of Squares36.8T

InflaRx Current Deferred Revenue History

2024 0.95
2023 1.0
20226.2 M
20211.4 M
20181.4 M

About InflaRx NV Financial Statements

InflaRx NV investors use historical fundamental indicators, such as InflaRx NV's Current Deferred Revenue, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in InflaRx NV. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue 1.00  0.95 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for InflaRx Stock Analysis

When running InflaRx NV's price analysis, check to measure InflaRx NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InflaRx NV is operating at the current time. Most of InflaRx NV's value examination focuses on studying past and present price action to predict the probability of InflaRx NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InflaRx NV's price. Additionally, you may evaluate how the addition of InflaRx NV to your portfolios can decrease your overall portfolio volatility.